Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations (2025) Hecker J, Plattner C, Cancino CA, Löscher BS, Saurenbach J, Letizia M, Rieder D, et al. Journal article ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanism (2025) Liu L, Müller T, Dedden M, Schramm S, Leppkes M, Atreya R, Atreya I, et al. Journal article Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study (2025) Noviello D, Chaparro M, Viganò C, Blesl A, Barberio B, Yanai H, Orlando A, et al. Journal article Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials (2025) Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, Mcgovern D, et al. Journal article Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies (2025) Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, et al. Journal article IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era? (2025) Atreya R, Neurath M Journal article, Editorial Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment (2025) Bokemeyer B, Plachta-Danielzik S, Gilman E, Di Giuseppe R, Deppe H, Mohl W, Teich N, et al. Journal article Intestinal interstitial fluid isolation provides novel insight into the human host-microbiome interface (2025) Avery EG, Haag LM, McParland V, Kedziora SM, Zigra GJ, Valdes DS, Kirchner M, et al. Journal article Update zur Diagnostik und Therapie der chronisch-entzündlichen Darmerkrankungen (2025) Atreya R Journal article No easy way out: blocking lymphocyte egress by the S1P1 receptor 1 modulator tamuzimod in ulcerative colitis (2025) Atreya R, Neurath M Journal article, Note